EsoGuard DNA test receives breakthrough designation

The FDA has given breakthrough device designation to the EsoGuard Esophageal DNA Test designed to help identity patients at higher risk for dysplasia due to chronic GERD, according to a press release from Lucid Diagnostics

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *